Alveo Technologies Appoints Veteran Biotech and Diagnostics Leader to Board of Directors
Roche executive Neil Gunn brings quarter-century of commercialization experience to infectious disease testing innovator
News provided by
Share this article
Share this article
ALAMEDA, Calif., May 13, 2021 /PRNewswire/ Alveo Technologies, Inc., an infectious disease testing leader, announced today biotechnology, diagnostics and medical device executive Neil Gunn has accepted an appointment to its board of directors.
To download a photo of Neil Gunn, click here.
Gunn, the retired president of Roche Sequencing Solutions, and current CEO of IDbyDNA, brings more than 25 years of healthcare industry experience to Alveo, with comprehensive knowledge and experience managing global product development, strategy development and commercial operations.
Infectious Disease Testing Leader Alveo Technologies Engages Amendola Communications
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Infectious Disease Testing Leader Alveo Technologies Engages Amendola Communications
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
ALAMEDA, Calif., March 17, 2021 /PRNewswire/ Alveo Technologies, Inc. (Alveo) announced today that it has been named a winner of the $6M XPRIZE Rapid COVID Testing Competition for its be.well COVID-19 Test. The be.well™ platform provides individuals access to molecular testing and cloud-based analytics for rapid diagnosis and management of infectious diseases.
(PRNewsfoto/Alveo Technologies)
The $6 million XPRIZE Rapid Covid Testing Competition challenged any and all innovators across the world to develop frequent, fast, cheap and easy COVID-19 screening solutions to help meet the surging demand for tests and relieve the global supply chain. Twenty finalist teams, including Alveo, were selected out of a pool of 219 semifinalists, with an initial 700 teams signing up. These semifinalists then had two weeks to send their testing kits and protocols to laboratories for clinical validation. Alveo won $500,000 as one of the top five team
Alveo Technologies be well COVID-19 Test Wins XPRIZE Rapid Covid Testing Competition
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.